Publicaciones en colaboración con investigadores/as de Hospitais da Universidade de Coimbra (87)

2024

  1. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

  2. Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

    Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97

2023

  1. Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies

    Autism Research, Vol. 16, Núm. 10, pp. 2021-2034

  2. Evolution of clinical and radiological presentations of spondyloepimetaphyseal dysplasia, RPL13-related: Description of 11 further cases

    Clinical Genetics, Vol. 104, Núm. 1, pp. 100-106

  3. Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database

    Rheumatology (Oxford, England), Vol. 62, Núm. 4, pp. 1559-1567

  4. Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey

    BMJ Open, Vol. 13, Núm. 3

  5. Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective

    The Lancet. Haematology, Vol. 10, Núm. 8, pp. e687-e694

2022

  1. 30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data

    International Journal of Obesity, Vol. 46, Núm. 4, pp. 750-757

  2. Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry

    Leukemia Research, Vol. 115

  3. Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781

  4. FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

    Blood Advances, Vol. 6, Núm. 2, pp. 690-703

  5. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

  6. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

    JAMA Dermatology, Vol. 158, Núm. 5, pp. 561-572

  7. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750

  8. Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura

    Medicina Clinica, Vol. 158, Núm. 12, pp. 630.e1-630.e14

  9. Role of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations

    Indian Journal of Critical Care Medicine, Vol. 26, Núm. 8, pp. 938-948

2021

  1. A generic curriculum development model for the biomedical physics component of the educational and training programmes of the non-physics healthcare professions

    Physica Medica, Vol. 85, pp. 32-41

  2. Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

    Journal of Autism and Developmental Disorders, Vol. 51, Núm. 8, pp. 2959-2972

  3. Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials) (Journal of Autism and Developmental Disorders, (2021), 51, 8, (2959-2972), 10.1007/s10803-020-04709-8)

    Journal of Autism and Developmental Disorders

  4. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78